Based on the research frontier of microbiome and immune regulation, Fojann has built a dual-core driving technology platform of "multi-omics big data +AI intelligent medicine", deeply integrating the core technologies in the three fields of biological information, artificial intelligence and clinical medicine, focusing on early screening of inflammatory bowel disease (IBD), microbial detection - accurate evaluation and effective intervention of immune system. To provide global users with a full chain of solutions fro risk warning to personalized health management.
With the "detection-intervention-tracking closed-loop system", Fojann realizes real-time optimization iteration of health management solutions through artificial intelligence medical systems. Moving forward, we will champion precision medicine innovations, leading the global transition from reactive healthcare to proactive prevention. Stewarding Microbial Frontiers in Service of the People's Wellness, we pioneer sustainable solutions to elevate the human biome civilization.